{
}
Investors are increasingly considering certificates on individual stocks, particularly from Leonteq and EFG International, as the S&P 500 and NASDAQ show significant gains. These products offer monthly coupons ranging from 0.67% to 1.33% gross, with potential annual yields between 8% and 16%. With barriers set between 50% and 70%, investors can focus on single equities while avoiding risks associated with multiple underlying assets.
The DAX, Germany's leading share index, tracks the performance of the 40 largest listed companies and serves as a key economic indicator. Introduced in 1988, it was expanded from 30 to 40 companies in 2021, reflecting a broader economic representation. The index is calculated daily and includes major sectors, with a focus on market capitalization and liquidity, making it a vital benchmark for investors.
The global cancer immunotherapy market is projected to reach $135.2 billion in 2024, growing at a CAGR of 9.8% to $236.9 billion by 2030, driven by rising cancer prevalence and demand for effective treatments. North America leads the market, while Asia-Pacific is the fastest-growing region. Monoclonal antibodies dominate the product segment, with lung cancer applications holding the largest market share, and breast cancer expected to grow the fastest.
The Congestive Heart Failure market is poised for significant growth, driven by an increase in prevalence and the introduction of innovative therapies like finerenone, tirzepatide, and semaglutide. Key players such as Novartis, Eli Lilly, and Bayer are advancing their drug candidates through clinical development, while off-label therapies and generics continue to dominate the current market landscape. The FDA's recent approvals and label expansions are expected to further enhance treatment options and accessibility for patients.
CRISPR Therapeutics has proposed the election of Briggs Morrison, M.D., to its Board of Directors at the upcoming annual general meeting. With over 30 years in the pharmaceutical industry, including leadership roles at AstraZeneca and Pfizer, Morrison's expertise in clinical development is expected to enhance the company's innovative pipeline. He has overseen the development of notable drugs such as Tagrisso®, Imfinzi®, and Lynparza®.
CRISPR Therapeutics has proposed the election of Briggs Morrison, M.D., to its Board of Directors at the upcoming annual general meeting. With over 30 years in the pharmaceutical industry, Morrison's expertise in clinical development is expected to enhance the company's innovative gene-based medicine initiatives. CRISPR Therapeutics, which celebrated the approval of the first CRISPR-based therapy in 2023, continues to advance its diverse portfolio targeting serious diseases.
[SEC](https://www.sec.gov) or [Bloomberg]
Bayer's CEO announced a significant restructuring aimed at reducing bureaucracy and enhancing agility, resulting in a drop in voluntary attrition despite 5,500 layoffs. The company is transitioning to self-directed teams and reallocating budgets every 90 days, with hopes of revitalizing its operations by 2025. However, Bayer faces substantial challenges, including a 44% drop in market cap, €34.5 billion in debt, and looming competition for its top drug, Xeralto, as exclusivity ends in 2026.
The Food for Special Medical Purpose market is poised for growth, driven by the rise in chronic illnesses and an aging population, particularly in Asia Pacific and Europe. Key players include Nestle, Danone Nutricia, and Abbott, with significant investments in R&D despite high costs and regulatory challenges. The market focuses on tailored nutritional solutions for infants, adults, and the elderly, reflecting evolving dietary needs.
The Global Uveitis Treatment market is projected to grow from USD 725 million in 2024 to USD 1.28 billion by 2032, with a CAGR of 8.5%. The study covers various treatment types, including corticosteroids and biologic agents, and offers customization options for regional and application-specific analysis. Key players include Novartis, Pfizer, and AbbVie, with North America leading the market and Asia-Pacific identified as the fastest-growing region.
Bayer AG
Companies
The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
investing in individual stock certificates with attractive monthly coupons
08:00 16.01.2025
DAX index reflects Germany's economic strength with expanded company representation
08:55 15.01.2025
global cancer immunotherapy market projected to reach 236.9 billion by 2030
United States Dollar
GSK plc
Bristol-Myers Squibb Company
Bayer AG
Eli Lilly and Company
Pfizer Inc.
Merck & Co., Inc.
Novartis AG
Immunocore Holdings plc
AstraZeneca PLC
Amgen Inc.
F. Hoffmann-La Roche Ltd.
IND
FRA
ARG
CAN
ESP
USA
BRA
CHN
MEX
DEU
ITA
JPN
GBR
KOR
Show more
10:06 10.01.2025
congestive heart failure market poised for significant growth by 2034
United States Dollar
Mesoblast Ltd
Eli Lilly and Co
Boehringer Ingelheim KG
Bayer AG
Merck & Co., Inc.
Bristol-Myers Squibb Co
Intra-Cellular Therapies, Inc.
BioCardia, Inc.
Novo Nordisk A/S
scPharmaceuticals Inc.
Lexicon Pharmaceuticals, Inc.
Cytokinetics, Incorporated
Novartis AG
Tenax Therapeutics, Inc.
AstraZeneca PLC
Amgen Inc.
Otsuka Pharmaceutical Co. Ltd.
FRA
DEU
ITA
JPN
GBR
USA
Show more
15:50 07.01.2025
crispr therapeutics proposes briggs morrison for board of directors election
United States Dollar
Vertex Pharmaceuticals Inc
AstraZeneca PLC
Bayer AG
Pfizer Inc.
Syndax Pharmaceuticals, Inc.
Merck & Co., Inc.
CHE
Briggs Morrison
Samarth Kulkarni
Show more
14:00 07.01.2025
CRISPR Therapeutics nominates Briggs Morrison for Board of Directors position
14:00 07.01.2025
crispr therapeutics proposes briggs morrison for board of directors appointment
14:00 07.01.2025
bayer implements major layoffs and restructuring to boost efficiency and agility
13:12 24.12.2024
growth prospects in the food for special medical purpose market
United States Dollar
Fresenius Kabi AG
Targeted Medical Pharma, Inc.
Danone Nutricia SL
Nestlé S.A.
Bayer AG
Ajinomoto Co., Inc.
AUT
CHE
JPN
ESP
USA
DEU
Nidhi Bhawsar
Show more
18:18 20.12.2024
global uveitis treatment market poised for significant growth by 2032
Pfizer Inc.
Bayer AG
Novartis AG
Regeneron Pharmaceuticals, Inc.
Merck & Co., Inc.
CIPLA LTD
Lupin Limited
Hoffmann-La Roche AG
Bausch Health Companies Inc.
BIOGEN
ABBVIE
Alimera Sciences Inc.
SAU
ISR
FRA
RUS
DEU
TWN
ARG
ARE
AUT
TUR
SGP
NZL
CHL
USA
BRA
CAN
ITA
JPN
IDN
GBR
ESP
IND
MYS
COL
AUS
THA
EGY
VNM
KOR
PHL
CHN
ZAF
MEX
Nidhi Bhavsar
Show more
20:41 19.12.2024
Trending
Subcategory
Corporate News
Industry Trends
Global Trade Developments
Stock Market Updates
Startups & Entrepreneurship
Cryptocurrency Trends
Industry Mergers & Acquisitions
Inflation and Monetary Impact
Supply Chain Management
Government Economic Policies
Central Bank Actions
Central Banks and Digital Currencies
Fintech Startups
Private Equity Deals
CEO Changes
Workplace Trends
Blockchain Infrastructure Development
Crypto Policies and Governance
Banking Regulations
Finance Mergers & Acquisitions
Countries:
Companies:
Apple Inc.
Foxconn Technology Co., Ltd.
NVIDIA Corporation
Nasdaq 100 Jun 25
Boeing Co
Airbus SE
Amazon.com, Inc.
Oracle AI USD
AppLovin Corp.
Tesmec S.p.A.
DeepSeek R1 USD
LG Electronics Inc.
Tesla, Inc.
MARA Holdings, Inc.
Cleanspark Inc
Citigroup Inc.
Vodafone Idea Limited
JM Financial Limited
Fuse Science, Inc.
Arla Foods A.M.B.A.
Currencies:
United States Dollar
Euro
Chinese Yuan
Egyptian Pound
Hong Kong Dollar
Indian Rupee
New Taiwan Dollar
People: